The BIONAT cohort", "sentences": [], "annotations": [], "relations": []}, {"offset": 49095, "infons": {"fpage": "375", "issue": "4", "lpage": "381", "name_0": "surname:Lieberman;given-names:LA", "name_1": "surname:Zeng;given-names:W", "name_2": "surname:Singh;given-names:C", "pub-id_pmid": "26718566", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "86", "year": "2016"}, "text": "CD62L is not a reliable bio-marker for predicting PML risk in natalizumab-treated R-MS patients", "sentences": [], "annotations": [], "relations": []}, {"offset": 49191, "infons": {"fpage": "447", "issue": "3", "lpage": "457", "name_0": "surname:Villar;given-names:LM", "name_1": "surname:Costa-Frossard;given-names:L", "name_2": "surname:Masterman;given-names:T", "pub-id_pmid": "25581547", "section_type": "REF", "source": "Ann Neurol", "type": "ref", "volume": "77", "year": "2015"}, "text": "Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab", "sentences": [], "annotations": [], "relations": []}, {"offset": 49378, "infons": {"fpage": "402", "issue": "5", "lpage": "409", "name_0": "surname:Khatri;given-names:BO", "name_1": "surname:Man;given-names:S", "name_2": "surname:Giovannoni;given-names:G", "pub-id_pmid": "19188571", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "72", "year": "2009"}, "text": "Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function", "sentences": [], "annotations": [], "relations": []}, {"offset": 49475, "infons": {"fpage": "885", "issue": "8", "lpage": "889", "name_0": "surname:Zhovtis Ryerson;given-names:L", "name_1": "surname:Frohman;given-names:TC", "name_2": "surname:Foley;given-names:J", "pub-id_pmid": "26917698", "section_type": "REF", "source": "J Neurol Neurosurg Psychiatry", "type": "ref", "volume": "87", "year": "2016"}, "text": "Extended interval dosing of natalizumab in multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 49537, "infons": {"fpage": "637", "issue": "6", "lpage": "644", "name_0": "surname:Dong-Si;given-names:T", "name_1": "surname:Gheuens;given-names:S", "name_2": "surname:Gangadharan;given-names:A", "pub-id_pmid": "25771865", "section_type": "REF", "source": "J Neurovirol", "type": "ref", "volume": "21", "year": "2015"}, "text": "Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy", "sentences": [], "annotations": [], "relations": []}, {"offset": 49653, "infons": {"fpage": "351", "issue": "2", "lpage": "358", "name_0": "surname:Ghezzi;given-names:A", "name_1": "surname:Grimaldi;given-names:LM", "name_2": "surname:Marrosu;given-names:MG", "pub-id_pmid": "21234775", "section_type": "REF", "source": "Neurol Sci", "type": "ref", "volume": "32", "year": "2011"}, "text": "Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group - Italian Neurological Society", "sentences": [], "annotations": [], "relations": []}, {"offset": 49783, "infons": {"fpage": "e325", "issue": "2", "name_0": "surname:Hodecker;given-names:SC", "name_1": "surname:Sturner;given-names:KH", "name_2": "surname:Becker;given-names:V", "pub-id_pmid": "28210661", "section_type": "REF", "source": "Neurol Neuroimmunol Neuroinflamm", "type": "ref", "volume": "4", "year": "2017"}, "text": "Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS", "sentences": [], "annotations": [], "relations": []}, {"offset": 49868, "infons": {"fpage": "486", "issue": "5", "lpage": "488", "name_0": "surname:Giacomini;given-names:PS", "name_1": "surname:Rozenberg;given-names:A", "name_2": "surname:Metz;given-names:I", "name_3": "surname:Araujo;given-names:D", "name_4": "surname:Arbour;given-names:N", "name_5": "surname:Bar-Or;given-names:A", "pub-id_pmid": "24476450", "section_type": "REF", "source": "N EnglJ Med", "type": "ref", "volume": "370", "year": "2014"}, "text": "Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome", "sentences": [], "annotations": [], "relations": []}, {"offset": 49946, "infons": {"fpage": "1144", "issue": "12", "lpage": "1152", "name_0": "surname:Landi;given-names:D", "name_1": "surname:De Rossi;given-names:N", "name_2": "surname:Zagaglia;given-names:S", "pub-id_pmid": "28228569", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "88", "year": "2017"}, "text": "No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML", "sentences": [], "annotations": [], "relations": []}, {"offset": 50028, "infons": {"fpage": "401", "issue": "2", "lpage": "403", "name_0": "surname:Maloney;given-names:E", "name_1": "surname:Molloy;given-names:A", "name_2": "surname:Al Hussona;given-nam